Is it Ever Too Early or Too Late

In this episode, Tom Caravela is joined by Jeff Vaughn and Dean McAllister to discuss the critical timing of Medical Science Liaison (MSL) involvement in drug development. They explore misconceptions and historical approaches, highlighting the impact and internal value of early MSL engagement. The conversation addresses challenges MSLs face, the adaptation to virtual engagement, and the importance of strategic prioritization within a global framework. They delve into the integration of AI and long-term clinical trial planning, emphasizing the need to bridge theory and practice. The episode concludes with insights on networking among industry leaders and sponsor appreciation.